Clopidogrel resistance and genetic factors
Dual antiplatelet therapy combining aspirin and clopidogrel is the standart care for patients WHO ave ACS or undergoing PCI according to guidelines.Itss well established that the antiplatelet response to clopidogrel varies widely among patients.Patients displaying little attenuation of platelet reac...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2013-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Dual antiplatelet therapy combining aspirin and clopidogrel is the standart care for patients WHO ave ACS or undergoing PCI according to guidelines.Itss well established that the antiplatelet response to clopidogrel varies widely among patients.Patients displaying little attenuation of platelet reactivity under therapy are recognized as clopidogrel resistant.Different mechanisms responsible for the phenomenon of clopidogrel resistance have been suggested with genetic polymorphisms being one of the most widely studied. |
---|---|
Item Description: | 1016-5169 10.5543/tkda.2013.49196 |